We are live on ! Find out more
IHM

Iguana Healthcare Management Portfolio holdings

AUM $152M
1-Year Est. Return 48.74%
This Fund
S&P 500
This Quarter Est. Return
-5.32%
1 Year Est. Return
+48.74%
3 Year Est. Return
+142.13%
5 Year Est. Return
10 Year Est. Return
AUM
$167M
AUM Growth
-$394M
Cap. Flow
-$366M
Cap. Flow %
-218.91%
Top 10 Hldgs %
44.66%
Holding
98
New
19
Increased
Reduced
39
Closed
38

Sector Composition

Rank Sector Weight
1 Healthcare 75.65%
2 Energy 0.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RARE icon
1
Ultragenyx Pharmaceutical
RARE
$2.54B
$11.3M 6.72%
160,000
-240,000
-60% -$17M
BIIB icon
2
Biogen
BIIB
$30.8B
$9.93M 5.93%
35,000
-30,000
-46% -$8.89M
MDCO
3
DELISTED
Medicines Co
MDCO
$9.33M 5.58%
275,000
-125,000
-31% -$4.43M
CELG
4
DELISTED
Celgene Corp
CELG
$9.26M 5.53%
80,000
-70,000
-47% -$7.8M
AMGN icon
5
Amgen
AMGN
$210B
$7.31M 4.37%
50,000
-60,000
-55% -$9.03M
ALXN
6
DELISTED
Alexion Pharmaceuticals
ALXN
$6.73M 4.02%
55,000
-95,000
-63% -$11.6M
MRK icon
7
Merck
MRK
$316B
$6.48M 3.87%
115,280
-41,920
-27% -$2.45M
ZBH icon
8
Zimmer Biomet
ZBH
$18.5B
$5.16M 3.08%
51,500
-123,600
-71% -$13.2M
NUVA
9
DELISTED
NuVasive, Inc.
NUVA
$4.71M 2.82%
70,000
-130,000
-65% -$8.38M
DERM
10
DELISTED
Dermira, Inc.
DERM
$4.55M 2.72%
150,000
-150,000
-50% -$4.83M
ABT icon
11
Abbott
ABT
$182B
$4.42M 2.64%
+115,000
New +$4.56M
AERI
12
DELISTED
Aerie Pharmaceuticals
AERI
$4.35M 2.6%
115,000
-215,000
-65% -$8.13M
OMED
13
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$4.24M 2.53%
550,000
-900,000
-62% -$8.27M
GKOS icon
14
Glaukos
GKOS
$10.1B
$4.12M 2.46%
120,000
-120,000
-50% -$4.11M
MZOR
15
DELISTED
Mazor Robotics Ltd.
MZOR
$3.84M 2.29%
175,000
-225,000
-56% -$5.07M
OEF icon
16
PUT
iShares S&P 100 ETF
OEF
$20.5B
$3.37M 2.01%
+25,000
New +$2.43M
CI icon
17
CALL
Cigna
CI
$72.4B
$3.33M 1.99%
25,000
-25,000
-50% -$3.27M
CLVS
18
DELISTED
Clovis Oncology, Inc.
CLVS
$3.33M 1.99%
75,000
-575,000
-88% -$20.2M
MRUS
19
DELISTED
Merus
MRUS
$3.17M 1.89%
150,000
-250,000
-63% -$4.27M
KTWO
20
DELISTED
K2M Group Holdings, Inc
KTWO
$3.01M 1.8%
150,000
-180,000
-55% -$3.42M
ALDR
21
DELISTED
Alder Biopharmaceuticals
ALDR
$2.91M 1.74%
140,000
-10,000
-7% -$260K
WBA
22
DELISTED
Walgreens Boots Alliance
WBA
$2.9M 1.73%
+35,000
New +$2.89M
ELV icon
23
Elevance Health
ELV
$82B
$2.88M 1.72%
20,000
-30,000
-60% -$4.02M
SPNC
24
DELISTED
Spectranetics Corp
SPNC
$2.69M 1.61%
110,000
-110,000
-50% -$2.59M
AGN
25
DELISTED
Allergan plc
AGN
$2.63M 1.57%
+12,500
New +$2.59M

Similar funds

Iguana Healthcare Management's Q4 2016 Portfolio in Review

As of Q4 2016, Iguana Healthcare Management held 98 positions worth $167M, down 70% from $561M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Iguana Healthcare Management withdrew a net $366M in Q4 2016, closing 38 positions and reducing 39 holdings. Its most notable exit was Pfizer, an estimated $16.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 76% of assets, up from 73% a quarter earlier, followed by Energy.

Against the trend, Iguana Healthcare Management opened a new position in Abbott worth $4.42M.

  • Iguana Healthcare Management's largest Q4 2016 buy was Abbott: 115,000 shares worth $4.42M.
  • Iguana Healthcare Management's biggest Q4 2016 reduction was Clovis Oncology, Inc., cutting an estimated $20.2M.
  • Iguana Healthcare Management fully exited Pfizer in Q4 2016, selling an estimated $16.9M.
  • Iguana Healthcare Management's ten largest holdings make up 45% of its $167M portfolio in Q4 2016.
  • Iguana Healthcare Management opened 19 new positions and closed 38 in Q4 2016.
  • Iguana Healthcare Management's portfolio value fell 70% quarter-over-quarter to $167M.

Based on Iguana Healthcare Management's 13F filing for Q4 2016, filed 14 Feb 2017.